logo
episode-header-image
Apr 2025
57m 41s

How do new cancer drugs affect our brain...

BMJ GROUP
About this episode
Immune checkpoint inhibitors can significantly improve cancer survival rates. But resulting immune-related toxicities are common, requiring multidisciplinary cooperation between oncology and neurology.  This episode, PN's podcast editor Dr. Amy Ross Russell speaks with a panel of experts on the balancing act required when treating cancer patients with these ... Show More
Up next
Oct 23
Suspected encephalitis in adults: a challenging diagnosis
Encephalitis, at its simplest, is inflammation of the functional tissue of the brain. With a wide range of infectious and non-infectious causes, it can be difficult to differentiate from other forms of encephalopathy. Yet a growing evidence base suggests that the time to treatmen ... Show More
42m 58s
Sep 29
Adoptive immunotherapy, updated MS criteria, and misleading meters - Editors' Highlights October 2026
A rare sight on the podcast: a paper from the cutting edge of practice, with the novel use of CAR-T cells in treating neurological diseases. Editors Phil Smith and Geraint Fuller bring a selection of papers from the October 2026 issue of the journal to discuss. Returning to the m ... Show More
51m 42s
Sep 16
Mystifying malabsorption, and brain stem syndromes - Case Reports August 2026
Diet continues to be a growing presence in the neurological diagnoses cropping up for the Case Reports team, returning again after its previous appearance with gastric sleeves. The first case (1:25), from UCLH in London, is that of a 49-yo woman, presenting with a history of wors ... Show More
45m 16s
Recommended Episodes
Sep 2020
Immunotherapy: Transforming How Cancers Are Treated
In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ... Show More
23m 44s
Sep 2024
Episode 200: Immune Checkpoint Inhibitors
We discuss a new class of medications, Immune Checkpoint Inhibitors, and their side effects. Hosts: Avir Mitra, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Immune_Checkpoint_Inhibitors.mp3 Download Leave a Comment Tags: Oncology Show Notes Ov ... Show More
13m 26s
Oct 2023
Immunotherapy Side Effects: Pneumonitis and More
Immunotherapy is a newer form of therapy for cancers. While immunotherapy is revolutionizing the management of many cancers, there can be unintended consequences and side effects associated with the therapy. In this episode of Respiratory Inspirations, two experts in pulmonary an ... Show More
22m 17s
Apr 2024
Impact of Immune Checkpoint Inhibitors
Drs. Justin Abbatemarco and Géraldine Androdias discuss the impact of immune checkpoint inhibitors on the course of multiple sclerosis.  Show reference:  https://www.neurology.org/doi/10.1212/NXI.0000000000200202  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for ... Show More
2m 8s
Oct 2024
152| Cancer Therapies and Brain Health – A Conversation with Dr. Mike Parsons and Dr. Jorg Dietrich
<p>In this episode on systemic, non-CNS cancer therapies and brain health, with Drs. Michael Parsons and Jorg Dietrich, we discuss basic concepts in cancer biology, the impact of cancer therapies on cognition, mechanisms by which non-CNS treatments impact brain health, the role o ... Show More
1h 48m
Feb 2024
Episode 64 - Neurologic Complications of Systemic Cancer Therapies
A discussion of the neurological complications of systemic cancer treatments, with Drs. Kevin Yan and Mary Barden.Note: This podcast is intended solely as an educational tool for learners, especially neurology residents. The contents should not be interpreted as medical advice.Fu ... Show More
37m 25s
Apr 2024
365: CardioOncology: Cardiotoxicity of Novel Immunotherapies with Dr. Tomas Neilan
Immunotherapy is a type of novel cancer therapy that leverages the body’s own immune system to target cancer cells. In this episode, we focused on the most common type of immunotherapy: immune checkpoint inhibitors or ICIs. ICIs are monoclonal antibodies targeting immune “checkpo ... Show More
57m 10s
Jun 2022
#342 Checkpoint Inhibitors: The power, and adverse effects, of immunotherapy (ACP 2022)
With great power comes great immunogenicity. Learn about the ins and outs of immunotherapy–its indications, its power, and its adverse effects–in this episode with Dr. Christian Cable, hematologist/oncologist and medical educator extraordinaire. We learn a riveting history of imm ... Show More
54m 36s
Aug 2023
Immunotherapy in TNBC: What's New, What's Next?
Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991253). The ... Show More
20m 52s